131 related articles for article (PubMed ID: 20840868)
1. Lentiviral delivery of meteorin protects striatal neurons against excitotoxicity and reverses motor deficits in the quinolinic acid rat model.
Jørgensen JR; Emerich DF; Thanos C; Thompson LH; Torp M; Bintz B; Fjord-Larsen L; Johansen TE; Wahlberg LU
Neurobiol Dis; 2011 Jan; 41(1):160-8. PubMed ID: 20840868
[TBL] [Abstract][Full Text] [Related]
2. Encapsulated cell-based biodelivery of meteorin is neuroprotective in the quinolinic acid rat model of neurodegenerative disease.
Tornøe J; Torp M; Jørgensen JR; Emerich DF; Thanos C; Bintz B; Fjord-Larsen L; Wahlberg LU
Restor Neurol Neurosci; 2012; 30(3):225-36. PubMed ID: 22426041
[TBL] [Abstract][Full Text] [Related]
3. Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice.
Zala D; Bensadoun JC; Pereira de Almeida L; Leavitt BR; Gutekunst CA; Aebischer P; Hayden MR; Déglon N
Exp Neurol; 2004 Jan; 185(1):26-35. PubMed ID: 14697316
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
Régulier E; Pereira de Almeida L; Sommer B; Aebischer P; Déglon N
Hum Gene Ther; 2002 Nov; 13(16):1981-90. PubMed ID: 12427308
[TBL] [Abstract][Full Text] [Related]
5. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
Emerich DF; Bruhn S; Chu Y; Kordower JH
Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
[TBL] [Abstract][Full Text] [Related]
6. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
[TBL] [Abstract][Full Text] [Related]
7. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral gene delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic acid-induced excitotoxicity.
Sanagi T; Yabe T; Yamada H
J Neuropathol Exp Neurol; 2010 Mar; 69(3):224-33. PubMed ID: 20142768
[TBL] [Abstract][Full Text] [Related]
9. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
[TBL] [Abstract][Full Text] [Related]
10. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.
Zala D; Benchoua A; Brouillet E; Perrin V; Gaillard MC; Zurn AD; Aebischer P; Déglon N
Neurobiol Dis; 2005 Dec; 20(3):785-98. PubMed ID: 16006135
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent neuroprotection of VEGF₁₆₅ in Huntington's disease striatum.
Ellison SM; Trabalza A; Tisato V; Pazarentzos E; Lee S; Papadaki V; Goniotaki D; Morgan S; Mirzaei N; Mazarakis ND
Mol Ther; 2013 Oct; 21(10):1862-75. PubMed ID: 23799534
[TBL] [Abstract][Full Text] [Related]
12. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
14. Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease.
Emerich DF; Mooney DJ; Storrie H; Babu RS; Kordower JH
Neurotox Res; 2010 Jan; 17(1):66-74. PubMed ID: 19588214
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
de Almeida LP; Zala D; Aebischer P; Déglon N
Neurobiol Dis; 2001 Jun; 8(3):433-46. PubMed ID: 11442352
[TBL] [Abstract][Full Text] [Related]
16. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
[TBL] [Abstract][Full Text] [Related]
17. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
18. AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment.
Kells AP; Henry RA; Connor B
Gene Ther; 2008 Jul; 15(13):966-77. PubMed ID: 18323792
[TBL] [Abstract][Full Text] [Related]
19. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
Popoli P; Pintor A; Domenici MR; Frank C; Tebano MT; Pèzzola A; Scarchilli L; Quarta D; Reggio R; Malchiodi-Albedi F; Falchi M; Massotti M
J Neurosci; 2002 Mar; 22(5):1967-75. PubMed ID: 11880527
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum.
Emerich DF; Winn SR
Cell Transplant; 2004; 13(3):253-9. PubMed ID: 15191163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
